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Background: Connectivity mapping is a process to recognize novel pharmacological and toxico-
logical properties in small molecules by comparing their gene expression signatures with others in
a database. A simple and robust method for connectivity mapping with increased specificity and
sensitivity was recently developed, and its utility demonstrated using experimentally derived gene
signatures.
Results: This paper introduces sscMap (statistically significant connections’ map), a Java ap-
plication designed to undertake connectivity mapping tasks using the recently published method.
The software is bundled with a default collection of reference gene-expression profiles based on the
publicly available dataset from the Broad Institute Connectivity Map 02, which includes data from
over 7000 Affymetrix microarrays, for over 1000 small-molecule compounds, and 6100 treatment in-
stances in 5 human cell lines. In addition, the application allows users to add their custom collections
of reference profiles and is applicable to a wide range of other ’omics technologies.
Conclusions: The utility of sscMap is two fold. First, it serves to make statistically significant
connections between a user-supplied gene signature and the 6100 core reference profiles based on
the Broad Institute expanded dataset. Second, it allows users to apply the same improved method
to custom-built reference profiles which can be added to the database for future referencing. The
software can be freely downloaded from http://purl.oclc.org/NET/sscMap.
I. BACKGROUND
Interaction of a drug or chemical with a biological sys-
tem can result in a gene-expression profile or signature
characteristic of the event. Lamb et al were the first
to propose using these data in connectivity mapping to
make connections between the pharmacological and toxi-
cological properties of small molecules [1]. The three key
components in the working of a connectivity map are: 1)
a collection of pre-built reference gene-expression profiles
that serves as a core database; 2) a query gene signature,
usually prepared by the user, which best characterizes a
compound-induced biological state and; 3) a similarity
metric to quantify the connection between a gene signa-
ture and a reference profile. In a previous publication [2]
we presented a simple and robust method for connecting
small-molecule drugs using gene-expression signatures,
the utility of which was shown using three experimen-
tally derived gene signatures from independent studies
for HDAC inhibitors [3], estrogen [4], and immunosup-
pressive drugs [5], respectively. Here in this paper we
describe sscMap, a Java application that implements the
method, and we focus on its utility and extensibility from
a user’s perspective.
II. IMPLEMENTATION
The software was built using Java programming lan-
guage (Java Platform, Standard Edition 6). JFC/Swing
classes were used to provide a Graphical User Interface
(GUI) of the program. In designing the software, user
extensibility was considered to be an important feature.
To this end each individual reference profile is stored as
a separate file on the disk. This setting greatly enhances
flexibility and extensibility of the software, as it allows
users to supplement the default collection of reference
profiles, or to build custom collection of reference profiles
by following a simple contract specified in the README
file. In the execution of the program, a set of reference
profiles are first loaded to memory and compared to all
the query gene signatures to calculate the related con-
nection scores and p-values, the memory is then released
and the program proceeds to load another set of reference
profiles from disk. This memory management scheme
enables the program to handle an anticipated increasing
number of reference profiles at a moderate cost of speed.
If all the available reference profiles were residing in mem-
ory, the number of reference profiles allowed would soon
be limited.
III. RESULTS
A. The core database
The Broad Institute released Build 02 of their Con-
nectivity Map (http://www.broad.mit.edu/cmap/) with
an expanded dataset over the 01 version with more com-
pounds utilized. Using these data we constructed 6100
reference gene-expression profiles using the method de-
scribed in our previous report [2]. In brief the genes were
2primarily sorted by the absolute value of log-ratios in de-
scending order, so that the most differentially expressed
gene has the highest rank. Thus sscMap comes with a de-
fault core database of 6100 reference profiles, each char-
acterizes a treatment instance as described in [1]. This
core database covers the treatment instances of over 1000
small-molecule compounds applied to 5 human cell lines.
So the primary utility of sscMap is for users who want
to compare their gene signatures to the reference pro-
files based on the Connectivity Map 02 dataset. The
benefits of the method implemented in this application
include a more principled statistical procedure [6, 7, 8],
effective safeguards against false connections, and an in-
creased sensitivity. The sscMap program can be run in
two execution modes: as a command line program, or as
a GUI (Graphical User Interface) application. In the sim-
ple command line mode using the built-in core database
users can simply put their gene signature files into the
queries folder and run the application. Detailed instruc-
tions and guided tours on how to run the program in
GUI mode can be found in the accompanying README
file. For more advanced application the database can be
added to at the users discretion as described below.
B. Extensibility: Building custom extensions
Users who want a greater capacity for comparison than
the built-in database can build up their own custom ref-
erence profiles and apply the same scoring scheme and
statistical testing procedures introduced in [2]. This sec-
tion briefly describes how users can customize the appli-
cation.
A plain text file, parameters.ini for the command
line mode, or for-gui/default-parameters.ini for the GUI
mode, sets the key parameters used by the program,
e.g., where to find the ref-files (reference gene-expression
profiles). In the default settings, we specified reffiles
as the default folder, where the 6100 reference profiles
are stored. It is possible to supplement them by sim-
ply putting more similarly built ref-files into the default
folder. Users can also create a new directory, for example,
custom-reffiles, and put all the custom ref-files there, and
then point the reference profiles folder to that directory,
either by editing the parameters.ini file for the command
line, or by browsing to the custom directory in the GUI
mode.
As an example, we have included with sscMap a folder
custom-example, which contains all the key components
of a customized extension to the application. Following
the example provided users should be able to build their
own extension. A more detailed description of the gen-
eral contracts for adding a custom collection of reference
profiles to sscMap can be found in the README file
accompanying the software.
C. Flexibility: Treatment set definition
The sscMap software downloads with a default ref-
files folder containing 6100 pre-built reference ex-
pression profiles. An example ref-file is azathio-
prine 0.1mM MCF7 338.ref.tab, which characterizes the
biological state of MCF7 cells treated with 0.1mM aza-
thioprine. The name of a typical ref-file is divided by the
underscore character , the default field separator, into
4 fields: drug name, dose, cell type, and instance ID,
respectively. The program allows users to specify which
field(s) to use for defining a “treatment set” (A term
we use interchangeably with “reference set”, or simply
ref-set elsewhere). Our preferred choice for the default
ref-files is to use the 3 fields: drug name (field 0), dose
(field 1), and cell type (field 2) together to define a treat-
ment set, meaning that only reference profiles with the
same drug, same dose, and same cell type should be re-
garded as forming a set in the set-level analysis. The
original Connectivity Map uses only the drug name to
define a treatment set, disregarding possible difference in
dose and cell type. This tends to average out the distinct
characteristics attributable to the cell type or dose dif-
ference, making some set-level connections insignificant
or their interpretation difficult. We described in the dis-
cussion section of [2] why it was preferable to use 3 fields
to define a treatment set. However, the program does
not force users to follow this preference. With sscMap,
users can choose whatever field(s) they feel appropriate
to define a set. One extreme case is to use all the fields of
a ref-file name, and consequently each treatment set will
have only one treatment instance (such a treatment set
is called a singleton set) and this reduces to the instance-
level analysis.
In the custom-example folder, the custom ref-files
names are divided by a custom filed separator, --, ie, two
hyphen characters, into 4 fields: drug name, dose, tissue
type, and time point, as in Drug2--LowDose--Tissue3-
-Day11.ref.tab. Treatment sets are defined using two
fields, Drug name (field 0) and Tissue type (field 2) in
this case. Thus the example here demonstrates the flexi-
bility offered by the application: users have the freedom
to choose their own field separator, the number of fields,
and which fields to define a treatment set.
D. Example 1: Using the default core collection of
ref-files
As an example of querying the default core database,
we used the five gene signatures previously reported
in [2]. Note that this default core database contains
6100 reference gene-expression profiles, which is a much-
expanded collection as compared to 453 in [2]. The con-
nection scores and p-values for the Estrogen gene sig-
nature are shown here in Figure 1 in graphical view.
The detailed tabulated results can be found as a tab file
(Estrogen.sig.sscmap.tab) in the results folder within the
3FIG. 1: A screenshot of the sscMap program displaying the
volcano plot for the Estrogen gene signature. The x-axis is
for the standardized connection score, while the y-axis is for
− log
10
p. The green horizontal line is for the pre-set threshold
p-value. Any data points above that line are considered as
statistically significant. In the example shown in this figure,
the threshold p-value was set as 1/N = 1/3738.
TABLE I: The connections of the rat reference profiles with
a mouse gene signature. n, set size; s, set score; p, p value; σ,
the standard deviation of random scores; z = s/σ.
ref-set n s p σ z
Drug2--Tissue2 3 0.0036 0.9716 0.0908 0.0394
Drug1--Tissue1 3 0.1553 0.0468 0.0790 1.9651
Drug1--Tissue2 3 0.0167 0.8638 0.0983 0.1694
Drug1--Tissue3 3 0.0221 0.7816 0.0799 0.2767
Drug2--Tissue1 3 -0.1934 0.0574 0.1020 -1.8953
Drug2--Tissue3 3 0.0648 0.3674 0.0709 0.9143
downloaded software.
E. Example 2: Using a custom collection of ref-files
In the folder custom-example we provided a small col-
lection of 18 custom reference profiles, constructed using
Affymetrix RAT230 2 microarray data. We then queried
this small database of custom reference profiles using 2
specially prepared gene signatures based on mouse cDNA
microarray data. To query the rat reference profiles using
mouse gene signatures, we first converted the gene IDs
on the mouse array to the Affymetrix Rat230 2 probeset
IDs, using the annotation file provided by Affymetrix.
The biological contexts of these reference profiles and
gene signatures in this example are not directly relevant,
as we are here simply demonstrating the possibility of ex-
tending the sscMap software with custom reference pro-
files. In Table I, we list all the connections of the 6 refer-
ence sets, each containing 3 individual reference profiles,
to one of the mouse gene signatures.
IV. CONCLUSIONS
The utility of sscMap is two fold. First, it serves to
make statistically significant connections between a user-
supplied gene signature and the 6100 core reference pro-
files based on the Broad Institute expanded dataset. Sec-
ond, it allows users to apply the scoring scheme and sta-
tistical procedures described in [2] to custom-built ref-
erence profiles which can be added to the database for
future referencing.
V. AVAILABILITY AND REQUIREMENTS
Project name: sscMap
Project home page: http://purl.oclc.org/NET/sscMap
Operating system(s): Platform independent
Programming language: Java
Other requirements: Java Runtime Environment 1.6
or later version is required to run the program.
License: None required for research and academic use.
Any restrictions to use by non-academics: For com-
mercial use, please contact the authors.
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